|
Volumn 20, Issue 1, 2014, Pages 18-24
|
A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States
a b c d e f g h i j k l m n o p q r s s,t more.. |
Author keywords
BRAF protein; brain neoplasms secondary; brain neoplasms drug therapy; clinical trial; human; humans; Melanoma drug therapy; melanoma genetics; neoplasm metastasis drug therapy; vemurafenib adverse effects; vemurafenib therapeutic use
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
ASPARTATE AMINOTRANSFERASE;
B RAF KINASE;
CREATINE KINASE;
IPILIMUMAB;
VEMURAFENIB;
INDOLE DERIVATIVE;
SULFONAMIDE;
ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD;
ADOLESCENT;
ADULT;
AGED;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ALOPECIA;
ARTHRALGIA;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
ASTHENIA;
BLURRED VISION;
BOWEN DISEASE;
BRAIN METASTASIS;
BULLOUS DERMATITIS;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CANCER RADIOTHERAPY;
CANCER STAGING;
CLINICAL ASSESSMENT;
COMPASSIONATE USE;
CONFUSION;
CONTROLLED STUDY;
DECREASED APPETITE;
DERMATITIS;
DIARRHEA;
DISEASE COURSE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
DRY EYE;
DRY SKIN;
ELECTROCARDIOGRAPHY;
ERYTHEMA;
EYE DISEASE;
EYE PAIN;
FATIGUE;
FEMALE;
FEVER;
FOLLICULITIS;
FOLLOW UP;
FOOD AND DRUG ADMINISTRATION;
FUNCTIONAL STATUS;
GENE MUTATION;
HAND FOOT SYNDROME;
HUMAN;
HYPERBILIRUBINEMIA;
HYPEREMIA;
HYPERKERATOSIS;
KERATOACANTHOMA;
LETHARGY;
LEUKOCYTE DISORDER;
LIP TUMOR;
LISTLESSNESS;
LIVER FUNCTION TEST;
LONG QT SYNDROME;
MACULOPAPULAR RASH;
MAJOR CLINICAL STUDY;
MALAISE;
MALE;
MEASLES LIKE RASH;
METASTATIC MELANOMA;
MIDDLE AGED;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
MYALGIA;
NAUSEA;
NEUTROPENIA;
NEUTROPHIL COUNT;
OCULAR HYPEREMIA;
OPEN STUDY;
PERIORBITAL EDEMA;
PERIPHERAL EDEMA;
PHASE 3 CLINICAL TRIAL;
PHOTOPHOBIA;
PHOTOSENSITIVITY;
PRIORITY JOURNAL;
PRURITUS;
PUSTULE;
QT PROLONGATION;
RASH;
RESPIRATORY FAILURE;
RISK ASSESSMENT;
SKIN CARCINOMA;
SUNBURN;
SYSTEMIC THERAPY;
TREATMENT DURATION;
TREATMENT RESPONSE;
UNITED STATES;
UVEITIS;
VERY ELDERLY;
VESICULAR RASH;
YOUNG ADULT;
CLINICAL TRIAL;
MELANOMA;
METASTASIS;
PATHOLOGY;
SKIN NEOPLASMS;
FEMALE;
HUMANS;
INDOLES;
MALE;
MELANOMA;
MIDDLE AGED;
NEOPLASM METASTASIS;
SKIN NEOPLASMS;
SULFONAMIDES;
UNITED STATES;
|
EID: 84893626912
PISSN: 15289117
EISSN: 1540336X
Source Type: Journal
DOI: 10.1097/PPO.0000000000000024 Document Type: Article |
Times cited : (45)
|
References (12)
|